December 15th, 2015

Company Update (NASDAQ:GILD): High Stakes Intrigue In Hep C: Bristol-Myers Vs. Gilead

[at Seeking Alpha] – Gilead’s ( GILD ) reluctance to marry its Hep C drug Sovaldi with Bristol-Myers Squibb’s ( BMY ) daclatasvir forced Bristol to take evasive action. Bristol applied to the . . . → Read More: Company Update (NASDAQ:GILD): High Stakes Intrigue In Hep C: Bristol-Myers Vs. Gilead Similar Articles: Stock Update: Biogen Idec Inc. (NASDAQ:BIIB) – [video] Biogen CEO: More products, company is focused Google Inc. (NASDAQ:GOOG) ~ HTC One KitKat update coming to Google Play edition smartphones Anadarko Petroleum Corporation (NYSE:APC) ~ Anadarko may sell China oil and gas project stakes, Reuters reports

Gilead Sciences Inc (NASDAQ:GILD) [at Seeking Alpha] – Gilead’s ( GILD ) reluctance to marry its Hep C drug Sovaldi with Bristol-Myers Squibb’s ( BMY ) daclatasvir forced Bristol to take evasive action. Bristol applied to the European Union for approval of …
Read more on … [visit site to read more]

Similar Articles:
  1. Stock Update: Biogen Idec Inc. (NASDAQ:BIIB) – [video] Biogen CEO: More products, company is focused
  2. Google Inc. (NASDAQ:GOOG) ~ HTC One KitKat update coming to Google Play edition smartphones
  3. Anadarko Petroleum Corporation (NYSE:APC) ~ Anadarko may sell China oil and gas project stakes, Reuters reports
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.